“Our PSG account services director is a dream to work with. The availability of a pharmacist for client contact/ communications is highly appreciated and lends tremendous credibility to the vendor. Keep up the good work!”
—Senior Account Manager, Third-Party Benefit Administrator
PSG has eight clinical pharmacists, giving us more clinical consulting capability than many PBMs and more than any other pharmacy benefit consulting firm in the country. Our clinicians are an integral part of the work we do to help clients reduce drug trend (annual rate of cost increase) in their pharmacy programs, which is key to maintaining a quality benefits program. Our clients enjoy trends significantly below the national average as a result of our focus in this area. All of our pharmacists have 10 or more years experience in the field. This real-life experience ensures delivery of practical solutions with a minimum amount of member disruption.
PSG’s clinical support services include:
To accurately assess and predict future claim costs in our client’s population, PSG uses claims-level detail to quantify the current impact of pharmaceuticals and to forecast potential growth in utilization and spend. PSG’s forecasting models include key assumptions regarding overall utilization, channel utilization, generic dispense rates, growth in key therapeutic classes, specialty drug utilization, anticipated impact of new drug launches (including generics), and many other factors. These assumptions are driven from monitoring industry trends, data mined from our data warehouse, and client-specific data/trend analysis.
In addition, our technology platform allows our clinical pharmacists and financial analysts to conduct a myriad of plan design modeling scenarios, including:
PBM formulary strategy has a material impact on both member satisfaction and overall costs. PSG has extensive experience evaluating the effectiveness of PBM formularies. The end result is a cost-effectiveness assessment of the PBM’s formulary approach, coupled with detailed recommendations for how to improve any shortcomings in the program. Our clinical analyses identify ways to drive to more cost effective medications through better product selection (e.g., generics, OTCs, therapeutic alternatives) and channel delivery (e.g., mail order, chains, etc.).
PSG recognizes the tremendous importance of clinical program initiatives and deploys experienced clinical pharmacy professionals to assist its clients in developing and deploying best-in-class clinical intervention approaches. Clinical support services are defined specifically in conjunction with each client, but typically include services such as:
© 2010 PSG - Pharmaceutical Strategies Group